1 / 7

Xerostomia Therapeutics Market Strategies and Forecasts, 2020 to 2026

Xerostomia usually called as dry-mouth ailment which occurs due to missing or decreased saliva. Generally, xerostomia is not considered as a disease, yet it is a problem which occurs due to numerous clinical scenarios such as adverse effects of radioactivity on head and also neck usually due to radiation treatment and negative effects of a variety of drugs and it might or might not be always related to the reduced functionality of salivary glands.

priyankauke2013
Download Presentation

Xerostomia Therapeutics Market Strategies and Forecasts, 2020 to 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Xerostomia Therapeutics Market Market Set to Exceed $822.1 Million By 2026 | CAGR 3.6%

  2. Xerostomia Therapeutics Market Size to Reach $822.1 Million By 2026 “Xerostomia (Dry Mouth) Therapeutics Market Size, Share, Trends, & Industry Analysis Report, By Product (Artificial Saliva, Dentifrices, Salivary Stimulants, Saliva Substitutes, Drugs, and Salivary Pen); By Distribution Channel; By Regions: Segment Forecast, 2019 - 2026” The global xerostomia therapeutics market size is expected to reach USD 822.1 million by 2026 growing at a CAGR of 3.6% during the forecast period according to a new report published by Polaris Market Research. Increase in favorable compensation plans for xerostomia products as well as increasing responsiveness and awareness about diseases associated with the condition are some of the major factors driving the market growth. Increasing occurrences of xerostomia as well as relevant medical conditions such as Parkinson’s disease, high blood pressure, Sjogren’s disorder, as well as diabetes mellitus has an affirmative impact on the international market. According to Colgate-Palmolive Company, it is estimated that more than twenty-five million people in the United States have the dry mouth problem. Similarly, Sjogren Syndrome Foundation estimates that more than four million people are suffering from Sjogren’s condition which is one the syndrome which causes dry mouth. However, to curb this problem, this foundation runs awareness programs in the U.S. for the people who are suffering from this condition and also to educate the public in general. This factor has also helped to push the overall market in this region. Along with different foundations creating awareness among the people, many of the major pharma companies are working towards acquisitions and joint ventures with emerging companies to increase their product portfolio and to create awareness among the people, further pushing the overall market. Browse Detailed Research Report On Xerostomia Therapeutics Market: https://www.polarismarketresearch.com/industry-analysis/xerostomia-therapeutics-market The global xerostomia therapeutics market report has been segmented by type, distribution-channel and region and it is anticipated that the market size was 625.3 million in 2018 and is estimated to grow at a CAGR of 3.6% from 2019 to 2026. The dentifrices market segment is expected to be the largest segment in 2018 due to its increased adoptability, reduced pricing and availability. This is closely followed by the salivary stimulants segment which is anticipated to have a high growth rate during the forecast period. Under the distribution channel segment, hospital pharmacy segment dominated the market in terms of revenue in 2018. This was majorly due to ease of accessibility, availability of branded as well as generic medicines and reduced item prices. Regionally, North America is estimated to be the major - 2 -

  3. Xerostomia Therapeutics Market Size to Reach $822.1 Million By 2026 region in 2018 followed by the European market. Increasing awareness among the people in these regions and initiatives taken by various foundations and companies are expected to push the market. Asia Pacific on other hand is expected to grow at a higher rate due to growing medical infrastructure and increased spending towards healthcare in developing countries such as India and China. Some of the leading companies in this market include Colgate-Palmolive Company, Church & Dwight Co., Inc, EUSA Pharma, GlaxoSmithKline plc, Forward Science, Mission Pharmacal Company, Eisai Inc., OraHealth Inc., Parnell Pharmaceuticals, Inc., OraPharma, Inc, Saliwell Ltd., Dentaid, and Sun Pharmaceutical Industries Limited. Request for sample: https://www.polarismarketresearch.com/industry-analysis/xerostomia- therapeutics-market/request-for-sample Table of Contents 1. Overview and Scope 1.1. Research goal & scope 1.2. Research assumptions 1.3. Research Methodology 1.3.1. Primary data sources 1.3.2. Secondary data sources 1.4. Key take-aways 1.5. Stakeholders 2. Executive Summary 2.1. Market Definition 2.2. Market Segmentation - 3 -

  4. Xerostomia Therapeutics Market Size to Reach $822.1 Million By 2026 3. Xerostomia Therapeutics Market Insights 3.1. Xerostomia Therapeutics – Industry snapshot 3.2. Xerostomia Therapeutics - Ecosystem analysis 3.3. Xerostomia Therapeutics Market dynamics 3.3.1. Xerostomia Therapeutics – Market Forces 3.3.1.1. Xerostomia Therapeutics Market driver analysis 3.3.1.2. Xerostomia Therapeutics Market restraint/challenges analysis 3.3.1.3. Xerostomia Therapeutics Market opportunity analysis 3.4. Industry analysis - Porter's five force 3.4.1. Bargaining power of supplier 3.4.2. Bargaining power of buyer 3.4.3. Threat of substitute 3.4.4. Threat of new entrant 3.4.5. Degree of competition 3.5. Xerostomia Therapeutics Market PEST analysis, 2017 3.6. Xerostomia Therapeutics Industry trends 3.7. Competitive Ranking Analysis 4. Xerostomia Therapeutics Market Size and Forecast by Products 4.1. Key findings 4.2. Artificial Saliva 4.2.1. Global market estimates and forecasts, 2017 – 2026 4.3. Dentifrices 4.3.1. Global market estimates and forecasts, 2017 – 2026 4.4. Salivary Stimulants 4.4.1. Global market estimates and forecasts, 2017 – 2026 4.5. Saliva Substitutes 4.5.1. Global market estimates and forecasts, 2017 – 2026 4.6. Drugs 4.6.1. Global market estimates and forecasts, 2017 – 2026 4.7. Salivary Pen 4.7.1. Global market estimates and forecasts, 2017 – 2026 5. Xerostomia Therapeutics Market Size and Forecast by Distribution Channel 5.1. Key findings 5.2. Hospital Pharmacies 5.2.1. Global market estimates and forecasts, 2017 - 2026 5.3. Retail Pharmacies 5.3.1. Global market estimates and forecasts, 2017 – 2026 5.4. Online Pharmacies 5.4.1. Global market estimates and forecasts, 2017 – 2026 6. Xerostomia Therapeutics Market Size and Forecast by Regions 6.1. Key findings 6.2. North America 6.2.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 6.2.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.2.3. U.S. 6.2.3.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 6.2.3.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.2.4. Canada 6.2.4.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 6.2.4.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.3. Europe 6.3.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 - 4 -

  5. Xerostomia Therapeutics Market Size to Reach $822.1 Million By 2026 6.3.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.3.3. Germany 6.3.3.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 6.3.3.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.3.4. UK 6.3.4.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 6.3.4.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.3.5. France 6.3.5.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 6.3.5.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.3.6. Italy 6.3.6.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 6.3.6.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.4. Asia Pacific 6.4.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 6.4.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.4.3. China 6.4.3.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 6.4.3.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.4.4. India 6.4.4.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 6.4.4.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.4.5. Japan 6.4.5.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 6.4.5.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.4.6. Australia 6.4.6.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 6.4.6.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.5. Latin America 6.5.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 6.5.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.5.3. Brazil 6.5.3.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 6.5.3.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.5.4. Mexico 6.5.4.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 6.5.4.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 6.6. Middle East & Africa 6.6.1. Xerostomia Therapeutics Market by Products, 2017 - 2026 6.6.2. Xerostomia Therapeutics Market by Distribution Channel, 2017 - 2026 7. Company Profiles 7.1. Eisai Inc. 7.1.1. Overview 7.1.2. Financials 7.1.3. Product Benchmarking 7.1.4. Recent Developments 7.2. Colgate-Palmolive Company 7.2.1. Overview 7.2.2. Financials 7.2.3. Product Benchmarking 7.2.4. Recent Developments 7.3. Dentaid - 5 -

  6. Xerostomia Therapeutics Market Size to Reach $822.1 Million By 2026 7.3.1. Overview 7.3.2. Financials 7.3.3. Product Benchmarking 7.3.4. Recent Developments 7.4. EUSA Pharma 7.4.1. Overview 7.4.2. Financials 7.4.3. Product Benchmarking 7.4.4. Recent Developments 7.5. Forward Science 7.5.1. Overview 7.5.2. Financials 7.5.3. Product Benchmarking 7.5.4. Recent Developments 7.6. GlaxoSmithKline plc 7.6.1. Overview 7.6.2. Financials 7.6.3. Product Benchmarking 7.6.4. Recent Developments 7.7. Mission Pharmacal Company 7.7.1. Overview 7.7.2. Financials 7.7.3. Product Benchmarking 7.8. OraHealth Inc. 7.8.1. Overview 7.8.2. Financials 7.8.3. Product Benchmarking 7.8.4. Recent Developments 7.9. OraPharma, Inc. 7.9.1. Overview 7.9.2. Financials 7.9.3. Product Benchmarking 7.9.4. Recent Developments 7.10. Parnell Pharmaceuticals, Inc. 7.10.1. Overview 7.10.2. Financials 7.10.3. Product Benchmarking 7.10.4. Recent Developments Access Press Release on Xerostomia Therapeutics Market: https://www.polarismarketresearch.com/press-releases/global-xerostomia-therapeutics- market About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and - 6 -

  7. Xerostomia Therapeutics Market Size to Reach $822.1 Million By 2026 chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 7 -

More Related